Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors ; volume:10 ; number:1 ; day:23 ; month:4 ; year:2019 ; pages:1-15 ; date:12.2019
Nature Communications ; 10, Heft 1 (23.4.2019), 1-15, 12.2019
- Klassifikation
-
Naturwissenschaften
- Urheber
-
Duan, Xiaopin
Chan, Christina
Han, Wenbo
Guo, Nining
Weichselbaum, Ralph R.
Lin, Wenbin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-019-09221-x
- URN
-
urn:nbn:de:101:1-2019051100563435583691
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Duan, Xiaopin
- Chan, Christina
- Han, Wenbo
- Guo, Nining
- Weichselbaum, Ralph R.
- Lin, Wenbin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy
Tumor immunosurveiliance: Innate immune activation as a mechanistic prerequisite for efficient immune checkpoint blockade in cancer immunotherapy
Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer
A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade
Local angiotensin II contributes to tumor resistance to checkpoint immunotherapy
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
TiSe2-mediated sonodynamic and checkpoint blockade combined immunotherapy in hypoxic pancreatic cancer
Dual immune checkpoint blockade in gastroesophageal tumors: never say never
Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy
Tumor immunosurveiliance: Innate immune activation as a mechanistic prerequisite for efficient immune checkpoint blockade in cancer immunotherapy
Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer
A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade
Local angiotensin II contributes to tumor resistance to checkpoint immunotherapy
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
TiSe2-mediated sonodynamic and checkpoint blockade combined immunotherapy in hypoxic pancreatic cancer
Dual immune checkpoint blockade in gastroesophageal tumors: never say never
Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockade
Are tumor size changes predictive of survival for checkpoint blockade based immunotherapy in metastatic melanoma?
A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy
Tumor immunosurveiliance: Innate immune activation as a mechanistic prerequisite for efficient immune checkpoint blockade in cancer immunotherapy
Tracking Neoantigens by Personalized Circulating Tumor DNA Sequencing during Checkpoint Blockade Immunotherapy in Non‐Small Cell Lung Cancer
A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade
Local angiotensin II contributes to tumor resistance to checkpoint immunotherapy
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
TiSe2-mediated sonodynamic and checkpoint blockade combined immunotherapy in hypoxic pancreatic cancer
Dual immune checkpoint blockade in gastroesophageal tumors: never say never
Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors